Myeloid-derived suppressor cells in cancer: Current knowledge and future perspectives
International Immunopharmacology · 2024-12 · 142 · 112949
DOI: 10.1016/j.intimp.2024.112949 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2024-12. Verfasst von Sunanda Rajkumari und 3 weiteren Autor:innen. Beteiligte Einrichtung: ICMR National Institute of Medical Statistics, Ansari Nagar, New Delhi 110029, India. Hauptthemen laut MEDLINE: Myeloid-Derived Suppressor Cells, Neoplasms, Tumor Microenvironment. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 328 Literaturangaben. Gefördert von: Indian Council of Medical Research.
Abstract (Originalsprache)
MDSCs (myeloid-derived suppressor cells) are crucial for immune system evasion in cancer. They accumulate in peripheral blood and tumor microenvironment, suppressing immune cells like T-cells, natural killer cells and dendritic cells. They promote tumor angiogenesis and metastasis by secreting cytokines and growth factors and contribute to a tumor-promoting environment. The accumulation of MDSCs in cancer patients has been linked to poor prognosis and resistance to various cancer therapies. Targeting MDSCs and their immunosuppressive mechanisms may improve treatment outcomes and enhance immune surveillance by developing drugs that inhibit MDSC function, by preventing their accumulation and by disrupting the tumor-promoting environment. This review presents a detailed overview of the MDSC research in cancer with regulation of their development and function. The relevance of MDSC as a prognostic and predictive biomarker in different types of cancers, along with recent advancements on the therapeutic approaches to target MDSCs are discussed in detail.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- ICMR National Institute of Medical Statistics, Ansari Nagar, New Delhi 110029, India.
- ICMR National Institute of Pathology, Safdarjung Hospital Campus, Ansari Nagar, New Delhi 110029, India.
- Asian Institute of Public Health University (AIPH) University, 1001 Haridamada, Jatani, Near IIT Bhubaneswar, Bhubaneswar 751002, India.
- Discovery Research Division, Indian Council of Medical Research, Ansari Nagar, New Delhi 110029, India. Electronic address: drsandeepagrawal25@gmail.com.
Förderung
- Indian Council of Medical Research
Zitieren
APA
Rajkumari, S., Singh, J., Agrawal, U., & Agrawal, S. (2024). Myeloid-derived suppressor cells in cancer: Current knowledge and future perspectives. International Immunopharmacology, 142, 112949. https://doi.org/10.1016/j.intimp.2024.112949
Vancouver
Rajkumari S, Singh J, Agrawal U, Agrawal S. Myeloid-derived suppressor cells in cancer: Current knowledge and future perspectives. International Immunopharmacology. 2024;142:112949. doi:10.1016/j.intimp.2024.112949
BibTeX
@article{Rajkumari2024,
author = {Rajkumari, Sunanda and Singh, Jaspreet and Agrawal, Usha and Agrawal, Sandeep},
title = {Myeloid-derived suppressor cells in cancer: Current knowledge and future perspectives},
journal = {International Immunopharmacology},
year = {2024},
volume = {142},
pages = {112949},
doi = {10.1016/j.intimp.2024.112949}
}
EUVIMED